Guadalupe Regional Medical Center in Seguin is now operating a regional infusion center capable of providing up to 50 monoclonal antibody infusions per day. The service is located within the hopital's Selig Room and Annex area on East Campus where patients are served through a partnership with the Texas Department of Emergency Management (TDEM).

TDEM is providing staffing resources through a third-party contract to provide the healthcare providers necessary to administer infusions. This helps relieve pressure off GRMC nursing staff who have been staffing and administering infusions seven days a week for the past few months. 

Patients who test positive for COVID-19 with mild to moderate disease and risk factors for progression to severe disease are candidates for monoclonal antibody infusions. Infusions are for treatment of active COVID-19 disease and should not be confused with the protective effect of vaccination. 

Patients who are eligible for the monoclonal antibody medication:
* Patient must NOT be hospitalized or require oxygen therapy.
* Patient must NOT require an increase in oxygen rate, if using for underlying condition, due 
to COVID-19.
* Patient MUST be within 10 days of symptom onset.

Patients can contact the infusion center by calling (830) 481-4332. Doctors can contact the infusion center to obtain a referral form by faxing a request to (830) 401-8267. 

More information about these COVID-19 therapeutics can be found at the following link:

Information for Patients

Get Notifications